Marty Makary left behind an FDA families learned not to trust
The article discusses the lack of trust in the FDA as expressed by families affected by its decisions. It highlights the views of Dr. Marty Makary, who criticizes the agency's transparency and efficiency. The piece reflects on the broader implications of bureaucratic processes in drug approval.
- ▪Families have learned to distrust the FDA due to its decision-making processes.
- ▪Dr. Marty Makary argues for greater transparency within the agency.
- ▪The article critiques the bureaucratic nature of drug approvals and its impact on public trust.
Opening excerpt (first ~120 words) tap to expand
Alex Wong/Getty Images {"customDimensions": {"2":"Jared Whitley","8":"bureaucracy, drug approval, fda, marty makary, mps, president trump, science, transparency, opinion \u0026 analysis","11":"opinion \u0026 analysis","7":"opinion","10":"05/19/2026"}, "post": {"id": 2676910379, "providerId": 0, "sections": [0, 2229864441, 545193419, 32156549], "authors": [27393624], "tags": ["bureaucracy", "drug approval", "fda", "marty makary", "mps", "president trump", "science", "transparency", "opinion \u0026 analysis"], "streams": [], "split_testing": {}} }
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Blaze.
Discussion
0 commentsMore from The Blaze
